We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Gum Arabic Detoxifies Gold Nanoparticles for Biomedical Use

By Biotechdaily staff writers
Posted on 14 Mar 2007
Nanotechnology researchers have used gum arabic as a matrix to stabilize and detoxify gold nanoparticles that can then be used for diagnostic or therapeutic purposes.

Gold nanoparticles (AuNPs) have exceptional stability against oxidation, and it is therefore expected that they will play a significant role in the progress of clinically useful diagnostic and therapeutic nanomedicines. More...
However, despite the huge potential for a new generation of AuNP-based nanomedicinal products, development of suitable, non-toxic AuNPs has proven to be difficult.

Gum arabic (GA) consists of a mixture of lower molecular weight polysaccharide and higher molecular weight hydroxyproline-rich glycoprotein. Because it is a mixture and the material varies significantly with source, the exact molecular structures are rather uncertain. Its glycoprotein is a high molecular weight hydroxyproline rich arabinogalactan with contiguous hydroxyprolines, oligo-alpha-1,3-L-arabinofurans, and non-contiguous hydroxyprolines galactose residues of oligo-arabinogalactans combining a beta-1,3-galactopyran core with rhamnoglucuronoarabinogalactose pentasaccharide side chains. The simultaneous presence of hydrophilic carbohydrate and hydrophobic protein provides its emulsification and stabilization properties. Emulsification is particularly enhanced due to molecular flexibility that allows greater surface interaction with the oil droplets.

In the current work, which was published in the February 2007 issue of Small, investigators from the University of Missouri (Columbia, USA) (1) used gum arabic to synthesize and stabilize nontoxic GA-AuNPs;(2) used GA-AuNPs for in vitro analysis and in vivo pharmacokinetics studies in pigs to gain insight into the organ-specific localization of this new generation of AuNP vector, and (3) performed x-ray computed tomography (CT) contrast measurements of GA-AuNP vectors to evaluate their potential utility in molecular imaging.

Results of these studies demonstrated that naturally occurring GA could be used as a nontoxic phytochemical construct in the production of readily administrable biocompatible AuNPs for diagnostic and therapeutic applications.
Senior author Dr. Kattesh Katti, professor of radiology and physics at the University of Missouri, said, "We found that gum arabic can effectively "lock” gold nanoparticles to produce nontoxic, nanoparticulate constructs that can be used for potential applications in nanomedicine. We have developed a new class of hybrid gold nanoparticles that are stable and can be administered either orally or through intravenous injection within the biological system.”


Related Links:
University of Missouri

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Hematology Consumables
Bioblood Devices
New
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Industry

view channel
Image: Pathlight combines WGS and dPCR to identify and longitudinally track large‑scale genomic changes, known as structural variants (photo courtesy of SAGA Diagnositcs)

Roche Affiliate Expands MRD Portfolio with SAGA Acquisition

Foundation Medicine, Inc., an independent affiliate of Roche, announced plans to expand its monitoring portfolio with SAGA Diagnostics’ Pathlight, a personalized, tumor-informed molecular residual disease... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.